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Failed or altered gliogenesis is a major characteristic of diffuse white matter injury in survivors of premature birth. The
developmentally regulated long noncoding RNA (lncRNA) H19 inhibits S-adenosylhomocysteine hydrolase (SAHH) and
contributes to methylation of diverse cellular components, such as DNA, RNA, proteins, lipids, and neurotransmitters. We
showed that the pregnancy-derived synthetic PreImplantation Factor (sPIF) induces expression of the nuclear receptor
corepressor 2 (NCOR2) via H19/SAHH-mediated DNA demethylation. In turn, NCOR2 affects oligodendrocyte
differentiation markers. Accordingly, after hypoxic-ischemic brain injury in rodents, myelin protection and
oligodendrocytes’ fate are in part modulated by sPIF and H19. Our results revealed an unexpected mechanism of the
H19/SAHH axis underlying myelin preservation during brain recovery and its use in treating neurodegenerative diseases
can be envisioned.
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Introduction
Advances in obstetric and neonatal care have successfully increased survival rates of  very premature 
infants, but the cost is the increase in preterm-specific brain injuries (1). The majority of  prematurity survi-
vors face long-term neurodevelopmental disabilities, including cerebral palsy, motor deficits, or/and cogni-
tive impairments that persist at least to young adulthood (2). The hallmark of  this injury is inflammation 
and altered gliogenesis with resulting diffuse white matter damage (3, 4). Neurogenesis and gliogenesis are 
precise spatially and temporally regulated processes, where neurons are generated in an inside-out fashion 
first, followed by the production of  astrocytes and/or oligodendrocytes (5, 6). In line with this notion, the 
peak period of  diffuse white matter injury occurrence (24–32 weeks of  gestation) coincides with the highest 
presence of  immature oligodendrocytes in the white matter (7, 8). Thus, targeting and modulating oligo-
dendrocytes’ fate in an immature brain after injury is an attractive strategy but has remained elusive (9, 10).
Gene methylation (5-methyl-cytosine) plays a critical role in mammalian development and is cat-
alyzed by the joint action of  3 S-adenosylmethionine–dependent DNA methyltransferases (DNMTs) 
(11). DNMTs and specific methylation/demethylation programs determine cell specificity and fate 
during neuro- and gliogenesis (12, 13). The specific interaction between DNMTs and long noncoding 
RNAs (lncRNAs) has emerged as an integral part of  corticogenesis (14). The developmentally regulat-
ed imprinted lncRNA H19 (called H19 herewith) is of  special interest. H19 is highly expressed during 
corticogenesis and plays important roles in embryo development and growth control (15). Besides its 
presence in embryonal tissues (16), H19 is detected in a subset of  postnatal and adult tissues, including 
the skeletal muscle (17, 18) and endometrium (19). H19 encodes a polyadenylated lncRNA of  approxi-
mately 2.6 kb, which is predominantly cytoplasmic, with a minor fraction also found in the nucleus (20). 
Importantly, H19 binds to S-adenosylhomocysteine hydrolase (SAHH) and inhibits its function both in 
vivo and in vitro (16, 21). SAHH is the major mammalian enzyme capable of  hydrolyzing S-adenosylho-
mocysteine (SAH) to homocysteine and adenosine and therefore SAH, as a potent feedback inhibitor of  
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S-adenosylmethionine–dependent methyltransferases, binds to DNMTs and prevents DNA methylation. 
The specific role of  H19 during gliogenesis is not known.
PreImplantation Factor (PIF) is an evolutionarily conserved embryo-derived peptide (MVRIKPGSANK-
PSDD) detectable in maternal circulation of  viable pregnancies, and similar to H19, it is expressed by the 
embryo/fetus and placenta (15, 22–26). Interestingly, besides PIF’s effects on maternal toleration and embryo 
implantation (27), a synthetic PIF analog (sPIF) was able to reverse and prevent paralysis and restore myelin-
ation through inhibiting neuroinflammation in murine models of  experimental autoimmune encephalomyeli-
tis (28, 29). The neuroprotective property of  sPIF was further underscored by its ability to mitigate microglial 
activation and neuronal loss while promoting neuronal migration in murine models of  perinatal brain injury 
(30, 31). These neuroprotective effects, at least in part, were due to altered miRNA let-7 synthesis (30). Nota-
bly, let-7 regulates radial migration of  neurons, and its bioavailability is affected by H19 (32, 33). Recently, 
sPIF was reported to modulate myoblast differentiation through the H19/mir-675/let-7 axis (17), and there-
fore we speculated that the sPIF/H19 axis may be involved in oligodendrocyte formation as well.
Given the emerging importance of  epigenetic regulation during corticogenesis (34) and DNA global 
methylation changes induced by H19 (21), we hypothesized that sPIF/H19 affects oligodendrocytes’ fate 
by S-adenosylmethionine–dependent DNA methylation. In the current study, we found that sPIF induced 
expression of  the nuclear receptor corepressor 2 (NCOR2) via H19/SAHH-mediated DNA demethylation. 
In turn, NCOR2 contributes to oligodendrocyte differentiation. We provide in vivo evidence that oligoden-
drocyte differentiation and myelin preservation are in part modulated by the sPIF/H19 pathway. Our results 
revealed an unexpected mechanism of  the H19/SAHH axis in myelin preservation during brain recovery, 
bearing the potential that the discovered H19/SAHH axis can be used as target in drug discovery programs.
Results
sPIF induces oligodendrocyte differentiation markers in an H19-dependent manner. To test whether sPIF/H19 
modulates oligodendrocyte differentiation markers, we used an immortal human-human hybrid cell line 
(MO3.13) that expresses phenotypic characteristics of  primary oligodendrocytes in an immature develop-
mental stage and rat oligodendrocyte precursor cells (35). We treated cells with sPIF or scrambled PIF pep-
tide (control) and detected increased markers of  myelinating, early differentiating oligodendrocytes, and 
oligodendrocyte progenitor cells, namely myelin basic protein, 2′,3′-cyclic nucleotide 3′-phosphodiesterase 
(CNPase), and oligodendrocyte transcription factor 2 (Olig2), at mRNA and protein levels (Figure 1, A–C). 
Given the importance of  H19 and PIF during embryogenesis (15, 22–26), we tested sPIF in the presence of  
H19-specific siRNA (siH19) next (Figure 1, D and E) (21). In line with previous results (17), sPIF increased 
the expression of  H19 significantly (Figure 1E), while losing the ability to induce oligodendrocyte differen-
tiation markers in the presence of  siH19 (Figure 1, D and E). Together, our results support the notion that 
sPIF induces oligodendrocyte differentiation markers in an H19-dependent manner.
H19 acts as a molecular sponge for let-7, contributing to differentiation of muscle (17, 18) or endome-
trium (19). We therefore aimed to test the role of  sPIF and let-7 next (30). For this purpose, we used a let-7– 
specific inhibitor (iLet7) concomitant with H19 knockdown (18). Notably, iLet7 is a chemically modified, sin-
gle-stranded nucleic acid that specifically binds to let-7 molecules and inhibits endogenous let-7 (12). Thus, cells 
transfected with siH19 plus iLet7 should mimic in part sPIF’s effects (reduced let-7 bioavailability) (17, 30). 
Surprisingly, siH19 plus iLet7 transfection did not increase oligodendrocyte differentiation markers (Figure 1F 
and Supplemental Figure 1; supplemental material available online with this article; https://doi.org/10.1172/
jci.insight.132335DS1), which suggests that the observed effects (Figure 1, A–E) are let-7 independent. These 
results further support the notion that sPIF induces markers of  different oligodendrocyte differentiation stages 
in an H19-dependent manner. Next, we thought to uncover the exact H19-mediated mechanism.
sPIF and H19 induce DNA methylation changes in oligodendrocytes. To dissect the role of  sPIF/H19 during 
oligodendrocyte differentiation, we treated cells with sPIF, human expression plasmid H19 (pH19), or con-
trol empty vector (Vec) (16) and measured SAHH activity. In line with the notion that H19 inhibits SAHH 
activity (16, 21), we detected a significant decrease after sPIF treatment or pH19 transfection (Figure 2A). 
Given that SAHH modulates DNMT-mediated DNA methylation (16, 21) and as a proof  of  principle, 
we performed global DNA methylation studies to identify downstream gene candidates regulating oligo-
dendrocyte differentiation. We used pH19, sPIF, and Vec in an MO3.13 cell line (n = 3 each group) again 
and performed genome-scale DNA methylation mapping using the platform of  an improved version of  
reduced representation bisulfite sequencing (RRBS). This platform offers the identification and analysis of  
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differentially methylated regions between samples at single-nucleotide resolution. As expected, both sPIF 
and pH19 induced extensive genome-wide methylation pattern changes relative to Vec (Supplemental Table 
1). We observed some genes showing increased methylation, others showing decreased methylation, and a 
third group with no significant changes. These changes are expected because methylation status of  a given 
cytosine residue within a gene locus is determined not only by the activity of  methyltransferases but also by 
other associated epigenetic marks known to influence the accessibility of  methyltransferases (21). Further, 
not all methyltransferases display an equal sensitivity to SAHH inhibition (36). Thus, H19 upregulation, 
via reduced SAHH activity, is expected to produce these different outcomes. Together, our results provide 
evidence that sPIF and H19 induce global methylation changes, and these are in part SAHH mediated. Next, 
we aimed to uncover the gene candidates regulating oligodendrocyte differentiation.
sPIF and H19 induce demethylation of  Ncor2. In search of  gene candidates regulating oligodendrocyte dif-
ferentiation, we detected that both sPIF and pH19 induced significant hypomethylation in the intron regions 
of  NCOR2 (Ncor2, also known as Smrt) (Supplemental Figure 2). NCOR2 is an intrinsically disordered 
hub protein, which binds and assists transcription factors and chromatin-modifying enzymes (37). This is 
Figure 1. sPIF induces oligodendrocyte differentiation markers in an H19-dependent manner. Hybrid cell line (MO3.13) that expresses phenotypic char-
acteristics of primary oligodendrocytes in an immature developmental stage and rat oligodendrocyte precursor cells were incubated with sPIF (100 and/
or 200 nM or control — Ctrl). RNAs and proteins were extracted 48 hours later, and levels were determined by qRT-PCR (A and C) and Western blots (B and 
C: representative Western blots). (D and E) Cells were transfected with control siRNA (siCtrl) or siRNA specific for H19 (siH19) or incubated with sPIF at 100 
and/or 200 nM or Ctrl. RNAs were harvested 48 hours after transfection and analyzed by qRT-PCR. (F) Cells were transfected with control siRNA (siCtrl) 
and/or control miRNA (siCon) and siRNA specific for H19 (siH19) or let-7 inhibitor (iLet7), and RNAs were harvested 48 hours after transfection and ana-
lyzed by qRT-PCR. Results are presented as mean ± SEM and are representative of at least 3 independent experiments. Single comparisons with Ctrl were 
made using a 2-tailed Student’s t test or Mann-Whitney test with Bonferroni’s correction. **P < 0.005; ***P < 0.0005. The levels of Ctrl and siCtrl were 
arbitrarily set to 1. Protein levels are presented after normalization to actin. Each experiment was conducted at least 3 times.
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of  interest since NCOR2 defends against the ability to initiate a differentiation program along a neuronal 
pathway in neural stem cells and modulates the astroglial differentiation in concert with NCOR1 (38). To 
confirm the detected hypomethylation (60% sPIF and pH19 versus Vec) of  the predicted Ncor2 intron region 
(Figure 2B), we performed bisulfite conversion followed by quantitative methylation-specific PCR analy-
sis using primers that specifically amplify the single differentially methylated region of  Ncor2. We detected 
reduced methylation of  the predicted CpG site (Figure 2C), in line with global methylation analysis (Figure 
2B). Since the hypomethylation of  intron regions may enhance the expression of  the downstream gene, we 
suspected that H19, by inhibiting SAHH and the methyltransferases, should ultimately stimulate the expres-
sion of  Ncor2. Therefore, we transfected cells with pH19 again and indeed, pH19 induced Ncor2 expression 
at mRNA and protein levels (Figure 2D). Together, these results strongly suggest that the sPIF/H19 axis 
regulates, SAHH dependently, the methylation and increase of  NCOR2, which ultimately should trigger the 
oligodendrocyte differentiation cascade.
To validate the hypothesis that oligodendrocyte differentiation is controlled by sPIF/H19/NCOR2, 
we used sPIF treatment in the presence of  NCOR2-specific siRNA (siNCOR2) in cells again (Figure 2E). 
Indeed, the presence of  siNCOR2 abolished sPIF’s ability to induce oligodendrocyte differentiation mark-
ers (Figure 2F), and NCOR2 overexpression resulted in similar effects (Figure 2G). Taken together, these 
results suggest that we uncovered a potentially novel signaling pathway that modulates oligodendrocyte 
differentiation markers (Figure 2H). We next decided to test the relevance of  this hypothesis in vivo.
sPIF and H19 induce differentiation of  cells from the subventricular zone. We decided to test the role of  sPIF 
and H19 on oligodendrocyte maturation in vivo using a murine model of  immature brain injury next. This 
model consisted of  LPS induction followed by ligation of  1 carotid artery and a hypoxic-ischemic period 
at P0/1 (Figure 3A). We chose this model because injury at this time point in mice corresponds in terms 
of  white matter development to very preterm human infants, who are highly susceptible to white matter 
damage (30, 31, 39–41). To follow up on the differentiation capacity of  oligodendrocytes, we used the injury 
model in combination with electroporation. Electroporation allows the selective labeling and manipulation 
of  radial glia cells from the subventricular zone (SVZ) and therefore follow-up on glial cells’ progeny (42). 
We electroporated all animals with the plasmid tdTomatoCAG that encodes the red fluorescent protein 
tdTomato to label neural progenitor cells and their progeny, and in the H19CA group, we used an active plas-
mid encoding H19 (pCMV-H19CA) to increase H19 activity in the electroporated cells. In the sPIF treatment 
group, we s.c. injected sPIF (0.75 mg/kg birth weight twice daily starting at injury time point). We analyzed 
the brains at P3 or P7. At P3, both sPIF and H19CA increased the differentiation (MASH-1 marker) of  cells 
labeled in the SVZ (Figure 3, B and D; compare sPIF and H19CA with injury). Notably, as a result of  asym-
metric division, these cells may generate transit-amplifying cells, which in turn have the potential to generate 
not only neurons in the olfactory bulb but oligodendrocytes in the white matter and cortex (5, 8). Therefore, 
we aimed to evaluate the generation of  an oligodendrocyte progenitor in P7 cells next.
sPIF and H19 induce oligodendrocyte differentiation and preserve myelin after injury. To understand the specif-
ic effect of  sPIF and H19CA during gliogenesis after injury, we used IHC and diffusion tensor imaging (DTI) 
on P7. First, we evaluated established precursor markers of  oligodendrocytes and focused on the corpus 
callosum and deep cortical layers (43, 44). Notably, these are the areas of  expected injury in an immature 
brain (30, 31, 39). We detected fewer SVZ-labeled cells differentiating to CNPase and OLIG2 after injury 
(Figure 3, C and D; compare injury and sham groups), which is in agreement with increased susceptibility 
of  oligodendrocyte precursors to an insult during gliogenesis (8, 45). Furthermore, both sPIF and H19CA 
increased the number of  SVZ-labeled cells expressing immature oligodendrocyte markers, suggesting an 
Figure 2. sPIF/H19 modulates oligodendrocyte differentiation markers by demethylation of Ncor2. MO3.13 cells were transfected with vector (Vec), 
H19-containing plasmid (pH19), or sPIF (200 nM) and after 48 hours analyzed. (A) We measured S-adenosylhomocysteine hydrolase (SAHH) and (B) per-
formed global genome methylation analysis. One specific sequence of the differentially methylated region–amplified (DMR-amplified) Ncor2 intron region 
with reduced methylated cytosine is highlighted in red. Numbers at the beginning and end of the sequence mark positions of the indicated nucleotides 
in the chromosome. The number above in red indicates the percentage of methylation in Vec compared with treatment (pH19 or sPIF; n = 3 each group). 
(C) We confirmed the specific hypomethylation site (as indicated in B) using quantitative methylation-specific PCR (QMSP) analysis. We measured Ncor2 
expression at mRNA and protein levels (representative Western blots) after pH19 transfection (D). We confirmed Olig2 and Mbp induction using pH19 (D) 
and Ncor2 silencing in (E). (F) We measured mature and immature oligodendrocyte expression markers after sPIF (200 nM) treatment and specific siN-
COR2 transfection. (G) These markers were measured after Ncor2 overexpression (G) as well. (H) Proposed model of sPIF to modulate oligodendrocyte fate 
by H19-induced hypomethylation of Ncor2. Single comparisons to Ctrl were made using a 2-tailed Student’s t test or Mann-Whitney test with Bonferroni’s 
correction. *P < 0.025; **P < 0.005; ***P < 0.0005. The levels of Ctrl and siCtrl were arbitrarily set to 1. Protein levels are presented after normalization to 
actin. Each experiment was conducted at least 3 times.
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increased generation of  oligodendrocyte precursors (Figure 3, C and D; compare green and red bars). 
These results suggest that both sPIF and H19CA modulate SVZ-derived glial cells after injury.
Given the impact of  sPIF and H19 on oligodendrocyte differentiation, we aimed to test the impact on 
myelination next. We used myelin basic protein IHC and DTI on P7. Notably, DTI and especially fraction-
al anisotropy are established MRI techniques to measure directional water diffusion in the nervous system 
(46). The fractional anisotropy scale ranges from 0 (isotropic) to 1 (anisotropic) and reflects the ratio of  the 
water diffusivity. Lower fractional anisotropy correlates with myelin loss (47), and the association between 
DTI measures and neuromotor performance is well defined (48, 49). We detected impaired myelin basic 
protein intensity (Figure 4, A and C; compare injury and sham groups) and reduced fractional anisotropy 
of  the corpus callosum in injured animals (Figure 4, B and C; compare injury and sham groups). Both sPIF 
and H19CA modulated these deficits significantly (Figure 4, A–C; compare green and red bars). Although 
we detected only a few SVZ-labeled cells expressing myelin basic protein (Figure 4A; red arrowheads in the 
panels), we provide evidence that sPIF modulates oligodendrocyte and myelin development after injury in 
part by H19 regulation, underlining the role of  SVZ-derived cells during brain maturation (8). Furthermore, 
the results provide evidence that the sPIF/H19/SAHH/NCOR2 regulatory axis (Figure 2H) is active in 
vivo and affects oligodendrocyte maturation.
Figure 3. sPIF/H19 impacts oligodendrocyte differentiation in vivo. (A) Experimental protocol indicating time points of electroporation, injury, treatment 
groups, and analyses. (B) Representative immunostainings of lateral ventricle (LV), cingulum, and partially caudate putamen at P3. The SVZ-labeled cells are  
red and SVZ/MASH1+ cells (differentiation marker) are indicated by yellow arrowheads (n = 3 each group). (C) Representative immunostainings of corpus callo-
sum and deep cortical layers on P7. The SVZ/CNPase+ (left panels) or SVZ/OLIG2+ cells (right panels) representing oligodendrocyte precursors derived from SVZ- 
labeled cells are indicated by yellow arrowheads, and red arrowheads indicate examples of CNPase+ or OLIG2+ cells (n = 5 each group). (D) Quantification of 
immunostaining on P3 and P7 using percentage of SVZ-labeled cells coexpressing specific marker (n = 8 each group). SVZ, subventricular zone. Scale bars: 50 
μm. All results are presented as mean ± SEM. **P < 0.01; ***P < 0.001 by 1-way repeated-measures ANOVA followed by Bonferroni’s multiple-comparison test.
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Discussion
We found that in vitro sPIF affected oligodendrocyte differentiation markers by increasing expression of H19, 
leading to decreased SAHH activity and global DNA methylation changes. One of the demethylated genes was 
Ncor2, which modulates gliogenesis. We also demonstrated that immediate s.c. supplementation of sPIF after 
immature brain injury in mice led to significant oligodendrocyte modulation, resulting in part in myelin pres-
ervation. Finally, sPIF-induced neuroprotection was in part due to H19-induced oligodendrocyte modulation.
Curiously, the adult brain expresses very low levels of  H19 (50), and in stroke H19 promotes neuroinflam-
mation (51). This is surprising because we demonstrated here that sPIF increased H19, and the inhibition of  
neuroinflammation in adult brains was previously reported (28, 29). However, we need to consider differences 
in the spatiotemporal expression and transcriptional alteration of  noncoding RNAs during brain development 
(52). Additionally, the influence of  additional methylation mechanisms such as DNA hydroxymethylation 
(5-hydroxymethylcytosine), which are prominent during postnatal development, need to be accounted for (53, 
54). It is conceivable that cofactors of  sPIF likely act in concert to elicit downstream effects that are specific to 
sPIF but different depending on the maturation stage of  the brain. Identification of  PIF-interacting cofactors 
is currently underway as in the case of  insulin-degrading enzyme in Alzheimer disease (55). The exact mech-
anisms of  how sPIF interacts with the cell to induce differentiation (upstream of H19) has not been addressed 
yet but is beyond the scope of  this manuscript.
Figure 4. sPIF/H19 modulates myelination in vivo. (A) Representative immunostaining of myelin basic protein from corpus callosum and deep cortical 
layers and (B) images from MRI (fractional anisotropy using diffusion tensor imaging). Red-edged insets represent magnification of the analyzed region 
of interest. (C) Quantification of white matter loss using immunostaining and fractional anisotropy. Scale bars: 50 μm. All results are presented as mean ± 
SEM. **P < 0.01; ***P < 0.001 by 1-way repeated-measures ANOVA followed by Bonferroni’s multiple-comparison test.
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Our study provides evidence that ambient cell-extrinsic cues affect maturation fate of oligodendrocytes in 
concert with a complex of cell-intrinsic epigenetic mechanisms (34). These include the spatiotemporal regula-
tion of cells during astrogliogenesis (5, 8). Although neurons are the first cell type arising from transit-amplify-
ing cells during development, different signals trigger DNA demethylation and may regulate the differentiation 
plasticity and therefore fate of these cells. However, we speculate that the regulation of the astroglial pathway 
depends on proper gene dosage of both NCOR1 and NCOR2, while differentiation along the neuronal pathway 
appears to be regulated by loss of NCOR2 alone (38). In line with this, NCOR2 mRNA is primarily expressed 
in the ventricular zone region, where multipotent neural precursors reside, whereas the expression of NCOR1 is 
more broadly distributed throughout the dorsal cortex.
We are aware that the role of NCOR in oligodendrogenesis is controversial. The absence of NCOR pro-
moted oligodendrocyte-associated gene expression (56), while histone acetylation modifier HDAC3 requires 
NCOR complex to promote deacetylation, leading to the repression of neuronal and increase of glial marker 
expression (57). Specifically, within the glial lineage, NCOR downregulated astrogenesis via JAK/STAT inhi-
bition and promoted oligodendrogenesis via deacetylation and inactivation of the astrogliogenesis-promoting 
factor STAT3 (58). We acknowledge that the specific NCOR1-NCOR2 interactions were not evaluated here and 
are beyond the scope of this manuscript. Additionally, we acknowledge that using immortal cells and murine 
oligodendrocyte precursor cells, which have not been differentiated to mature oligodendrocytes, has certain lim-
itations. Also, the exact postnatal SVZ cell fate after injury was not studied.
We propose that the epigenetic regulatory pathway in Figure 2H may underlie the DNA methylation 
dynamics associated with development and diseases, such as the regulation of neuronal fate program (38). Giv-
en the importance of PIF during embryonal/fetal development (23, 59) and the high expression of H19 during 
this period (15, 16), the question whether the sPIF/H19 axis is active beyond oligodendrocyte modulation and 
the impact on preterm birth or preeclampsia remains to be investigated (26). Further investigation is necessary to 
evaluate the exact mechanisms and fate of SVZ-derived cells after injury (8). Our results provide evidence that 
sPIF modulates the fate of SVZ-derived cells supporting neuroprotection, but clinical trials in immature infants 
warrant deeper understanding. sPIF has a short half-life in circulation (60) and despite this rapid clearance, we 
and others observed neuroprotection (28–31). This would indicate that the circulating PIF concentration is not a 
good indicator of the local concentration of sPIF at its site of action and the need to use higher concentrations 
of sPIF in cell culture experiments (30). This would lead to the question of proper dosage during pregnancy or in 
the neonate. Given sPIF’s safety profile, the FDA’s fast-track approval for clinical trials in autoimmune hepatitis 
(60), and the pregnancy-derived origin (27), the acceptance and use of sPIF in pregnancy or the neonate can be 
envisioned. A phase I safety study in preterm infants at risk of brain injury is currently in preparation.
Methods
Induction of  immature brain injury and electroporation. Four pregnant SD-1 mice were purchased from Charles 
River Laboratories, and 32 neonatal animals were randomly divided into 4 groups (Sham, Injury, and Inju-
ry+sPIF, Injury+H19CA; n = 8 in each group). All animals were electroporated at P0 using a tdTomato- 
encoding plasmid (tdTomatoCAG) to label neural progenitor cells from the SVZ and their progeny. Animals 
in the Injury+H19CA group additionally received an active plasmid encoding H19 (pCMV-H19CA). Electropo-
ration was performed as we previously described (61). Plasmids (1–2 mg/mL) were diluted in PBS containing 
0.1% fast green as a tracer. A total of 0.5–1 mL of plasmid solution was injected into the lateral ventricles of  
cold-anesthetized neonatal pups using a pulled glass pipette (diameter <50 mm). Five square pulses of 50 ms 
duration with 950 ms intervals at 100 V were applied using a pulse ECM830 BTX generator and tweezers-type 
electrodes (model 520; BTX) placed on the heads of P0 pups. We used the following plasmids: tdTomato-RFP 
(61), pCAG-RFP (61); active plasmid encoding H19 (pCMV-H19CA; see Supplemental Methods); and vector 
(Ambion, AM4636) as control. We induced injury as previously reported (30, 31, 39). Briefly, animals received 
LPS (0.1 mg/kg BW, i.p. at P0/1) and 12 hours later, 1 common carotid artery was dissected and cauterized 
using a stereomicroscope. Animals were subjected to 40 minutes of hypoxia (8% O2/92% N2), resulting in a 
unilateral white matter injury to the corpus callosum and deep cortical layers, mimicking injury in survivors of  
premature birth (30, 31, 39). Starting after induction of injury, we performed the following treatments: the Inju-
ry and Injury+H19CA groups received PBS; the Injury+sPIF group received sPIF (0.75 mg/kg birth weight s.c. 
twice daily until tissue harvesting). The Sham group consisting of sham-operated animals (0.9% NaCl instead 
of LPS, exposure of carotid artery without ligation, no hypoxia) received PBS and was the control group. We 
harvested the brains on P3 (n = 3 each group) and P7 (n = 5 each group) for further analyses.
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Cultured cells and treatments. We obtained rat oligodendrocyte precursor cells (ROPCs) from ScienCell 
Research Laboratories. These cells were isolated from P2 rat brain and characterized by immunofluorescence 
with antibodies specific for A2B5 and O1. ROPCs were cryopreserved and delivered frozen. Upon delivery, we 
seeded and grew cells according to the manufacturer’s protocol. Briefly, cells were seeded at a density of 10,000 
or more cells/cm2 in 6-well chamber slides in oligodendrocyte precursor cell medium supplemented with PBS 
and 1× penicillin/streptomycin. The chambers were coated with poly-L-lysine according to the manufacturer’s 
recommendations prior to the seeding of ROPCs. We used oligodendrocyte precursor cell differentiation medi-
um (OPCDM, 1631). We replenished the medium after 24 hours and then exposed cells to PIF (200 nM) for 
72 hours. The sPIF peptide was replenished every 24 hours in fresh serum-free media until RNA and protein 
extraction for further analyses. We repeated each experiment at least 3 times.
MO3-13 cells (CELLution Biosystems Inc.) are an immortal human-human hybrid cell line with the pheno-
typic characteristics of primary oligodendrocytes. Cell were grown in DMEM (GIBCO Invitrogen), containing 
4.5 g/L glucose (GIBCO), supplemented with 10% FBS (Sigma-Aldrich), 100 U/mL penicillin, and 100 μg/mL 
streptomycin. The cells were kept in a 5% CO2 and 95% air atmosphere at 37°C. Trypsin-EDTA 0.25% (Thermo 
Fisher Scientific) was used to detach cells from culture plates. For treatments, cells were seeded in 24-well plates 
in regular growth media at a density of approximately 1.5 × 105 per well. The next day, media were replaced with 
serum-free media containing sPIF or scrambled PIF (scrPIF) (see supplemental material) at the final concentra-
tion of 100 nM or 200 nM, followed by incubation for 48 hours. The sPIF or scrPIF peptide was replenished 
every 24 hours in fresh serum-free media until RNA and protein extraction for further analyses. For overexpres-
sion and silencing experiments, cells were transfected in a 24-well plate. To prepare siRNA transfection solution 
for each well, 30 pmol of control siRNA (siCon) or siH19 was mixed with 100 μL OPTI-MEM by gentle pipet-
ting. In parallel, 3 μL Lipofectamine 2000 was mixed with 100 μL OPTI-MEM. After 5 minutes of incubation at 
room temperature, the two were mixed by gentle pipetting and incubated for 20 to 30 minutes at room tempera-
ture to allow siRNA/lipid complexes to form. At the end of incubation, the 200 μL transfection solution was used 
to resuspend the cell pellet (~1.5 × 105 cells/well). After incubation at room temperature for 10 minutes, regular 
growth medium was added at a ratio of 1:5 (1 volume of transfection solution/4 volumes of growth medium) 
and the cell suspension was transferred to the culture plate. After 24 hours of incubation at 37°C in 5% CO2, the 
medium was replaced with fresh growth medium. RNAs and proteins were extracted and analyzed at the indi-
cated time points after transfection. Plasmid DNA transfections were carried out as described for siRNA, except 
that 1 μg DNA in 25 μL OPTI-MEM and 1 μL Lipofectamine 2000 in 25 μL OPTI-MEM were used for each well 
of cells (the 50 μL of final transfection reagent with 500 μL of regular growth medium was added to each well).
In vivo SAHH activity assay. The experiments were performed in a 96-well scale using the Human Homo-
cysteine (Hcy) ELISA Kit (MBS260128, Mybiosource) that allows quantitative measurement of homocysteine 
concentration in cell extracts, according to the manufacturer’s instructions. The concentration of homocysteine 
in cell extracts was used as a readout for in vivo SAHH activity because SAHH hydrolyzes SAH to homocysteine 
and adenosine. Briefly, cells were washed with cold PBS and lysed on plates in 200 μL of lysis buffer (40 mM 
hexadecyltrimethylammonium bromide, 75 mM Tris-HCl, 1 M NaCl, 15 mM EDTA). The lysate was cleared of  
insoluble materials by centrifugation at 15000g at 4°C for 15 minutes. Immediately after the centrifugation, 100 
μL of the supernatant was collected and used for SAHH activity measurement. The absorbance of the samples 
was determined using a Multi-Mode Microplate Reader (Fluoroskan Ascent FL Microplate Fluorometer and 
Luminometer, Thermo Fisher Scientific).
Antibodies, siRNAs, and plasmids. See Supplemental Methods for details.
Western blot and quantitative RT-PCR. See Supplemental Methods for details.
RRBS and methylation-specific PCR. See Supplemental Methods for details.
Microscopy and DTI experiments. See Supplemental Methods for details.
Statistics. See Supplemental Methods for details.
Study approval. All present studies in animals were reviewed and approved by an appropriate institutional 
review board and approved by the Institutional Animal Care and Use Committee of Yale University (IACUC 
2013-10614).
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